BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 154 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $169,000 | -19.5% | 54,534 | -6.2% | 0.00% | – |
| Q3 2021 | $210,000 | -6.7% | 58,158 | -7.3% | 0.00% | – |
| Q2 2021 | $225,000 | -4.3% | 62,712 | +4.5% | 0.00% | – |
| Q1 2021 | $235,000 | -2.5% | 60,010 | +4.4% | 0.00% | – |
| Q4 2020 | $241,000 | +17.6% | 57,454 | +4.5% | 0.00% | – |
| Q3 2020 | $205,000 | -12.0% | 54,982 | 0.0% | 0.00% | – |
| Q2 2020 | $233,000 | +12.0% | 54,982 | +0.3% | 0.00% | – |
| Q1 2020 | $208,000 | -36.0% | 54,830 | +6.6% | 0.00% | – |
| Q4 2019 | $325,000 | +38.3% | 51,422 | -6.0% | 0.00% | – |
| Q3 2019 | $235,000 | -7.1% | 54,701 | +0.5% | 0.00% | – |
| Q2 2019 | $253,000 | +3062.5% | 54,448 | +1918.8% | 0.00% | – |
| Q2 2018 | $8,000 | +33.3% | 2,697 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | -25.0% | 2,697 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | +14.3% | 2,697 | +21.1% | 0.00% | – |
| Q3 2017 | $7,000 | +75.0% | 2,228 | +70.1% | 0.00% | – |
| Q2 2017 | $4,000 | +33.3% | 1,310 | -9.8% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 1,452 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | -25.0% | 1,452 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 1,452 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -97.3% | 1,452 | -95.6% | 0.00% | – |
| Q1 2016 | $111,000 | -27.9% | 33,099 | +3.4% | 0.00% | – |
| Q4 2015 | $154,000 | -11.0% | 32,016 | +2.7% | 0.00% | – |
| Q3 2015 | $173,000 | -28.8% | 31,172 | +2.1% | 0.00% | – |
| Q2 2015 | $243,000 | -18.2% | 30,540 | +8.1% | 0.00% | – |
| Q1 2015 | $297,000 | -8.9% | 28,253 | +4.3% | 0.00% | – |
| Q4 2014 | $326,000 | -31.8% | 27,096 | -3.2% | 0.00% | -100.0% |
| Q3 2014 | $478,000 | +44.8% | 27,997 | +2.4% | 0.00% | 0.0% |
| Q2 2014 | $330,000 | +64.2% | 27,346 | +15.0% | 0.00% | – |
| Q1 2014 | $201,000 | +36.7% | 23,773 | -4.7% | 0.00% | – |
| Q4 2013 | $147,000 | +177.4% | 24,945 | +157.5% | 0.00% | – |
| Q3 2013 | $53,000 | – | 9,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |